期刊文献+

血管紧张素转化酶抑制剂的药动学-药效学关系

Pharmacokinetic and pharmacodynamic relationships of angiotensin-converting enzyme inhibitors
下载PDF
导出
摘要 从药动学-药效学结合模型的角度出发,通过几种血管紧张素转化酶抑制剂在临床治疗学及临床药效学上的应用,概述了血管紧张素转化酶抑制剂的药动学与药效学关系,尤其是血浆ACEI浓度、血管紧张素Ⅱ浓度、血管紧张素转化酶抑制作用及血压四者之间的相互关系. The interrelationships between the pharmaeokinetic and pharmacodynamic behaviour ofACE inhibitors are reviewed. A pharmacokinetic-dynamic model is descrived which seems to be usefulfor the interpretation of the complex biochemical processes. The various correlations between plasmadrug concentration on the one hand and plasma ACE activity,angiotensin II Concentration in plasma orblood pressure on the other hand, are discussed on the basis of this model.
出处 《海军总医院院刊》 1994年第3期172-175,共4页
关键词 血管紧张素 转化酶抑制剂 药代动力学 药理 <Keyword>Angiotensin converting enzyme inhibitors Pharmacokinetics Pharmacodynamics Combined pharmacokinctic and pharmacodynamic model
  • 相关文献

参考文献1

  • 1P. U. Witte,R. Irmisch,P. Hajdú,H. Metzger. Pharmacokinetics and pharmacodynamics of a novel orally active angiotensin converting enzyme inhibitor (HOE 498) in healthy subjects[J] 1984,European Journal of Clinical Pharmacology(5):577~581

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部